Belden (BDC) Tops Q3 EPS by 7c, Posts Weak Q4 Guidance, Narrows FY11 Guidance
Tweet
Share
E-mailGet Alerts BDC Hot Sheet
Price: $137.16 -0.63%
Financial Fact:
Net income (loss): 35.65M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Net income (loss): 35.65M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Belden (NYSE: BDC) reported Q3 EPS of $0.65, $0.07 better than the analyst estimate of $0.58. Revenue for the quarter came in at $519.7 million versus the consensus estimate of $508.51 million.
Belden sees FY2011 EPS of $2.33-$2.38, versus the consensus of $2.37. Belden sees FY2011 revenue of $2.01-$2.02 billion, versus the consensus of $2.02 billion.
Belden sees Q4 2011 EPS of $0.50-$0.55, versus the consensus of $0.62. Belden sees Q4 2011 revenue of $490-$500 million, versus the consensus of $517.44 million.
Belden sees FY2011 EPS of $2.33-$2.38, versus the consensus of $2.37. Belden sees FY2011 revenue of $2.01-$2.02 billion, versus the consensus of $2.02 billion.
Belden sees Q4 2011 EPS of $0.50-$0.55, versus the consensus of $0.62. Belden sees Q4 2011 revenue of $490-$500 million, versus the consensus of $517.44 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
- Eledon Pharmaceuticals, Inc. (ELDN) Misses Q2 EPS by 12c
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
